Keywords: lilly, advance, ly519818, into, ph, iii, ligand

Lilly to advance LY519818 into Ph III

Article | 08 March 2004

Print This

Ligand Pharmaceuticals has reported that drug major Eli Lilly is to advance LY519818 into Phase III registration studies. The agent ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in